Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A One-year, Multicountry, Multicenter Study of Zemplar Injections in Patients With End Stage Chronic Kidney Disease, Undergoing Hemodialysis, Not Adequately Controlled With Oral Vitamin D Receptor Activator (Calcitriol or Alfacalcidol)

NCT01084538 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT01084538
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01084538 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A One-year, Multicountry, Multicenter Study of Zemplar Injections in Patients With End Stage Chronic Kidney Disease, Undergoing Hemodialysis, Not Adequately Controlled With Oral Vitamin D Receptor Activator (Calcitriol or Alfacalcidol)
Lead sponsor
Abbott
Phase
Observational
Overall status
Completed
Start date
September 30, 2007
Completion date
June 30, 2010
Enrollment
181 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

parathyroid hormone